Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare ConferenceGlobeNewsWire • 04/01/24
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsGlobeNewsWire • 03/04/24
How Much Upside is Left in Avadel (AVDL)? Wall Street Analysts Think 37.36%Zacks Investment Research • 01/15/24
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial ResultsGlobeNewsWire • 11/08/23
Avadel Pharmaceuticals Announces Data Supporting Clinical Profile for LUMRYZ™ (sodium oxybate) for extended-release oral suspension (CIII) at World Sleep 2023GlobeNewsWire • 10/20/23
Avadel Pharmaceuticals: A Resilient Buy; A Comprehensive Assessment Of Potential ProspectsSeeking Alpha • 08/22/23
Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2023 Financial ResultsGlobeNewsWire • 08/09/23
Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter Financial Results on August 9GlobeNewsWire • 08/02/23
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 07/20/23
Avadel Pharmaceuticals to Host Commercial Day on June 29 for LUMRYZ™ (sodium oxybate) extended release for oral solution, CIIIGlobeNewsWire • 06/22/23
Avadel Pharmaceuticals Sponsors the Academy of Sleep Medicine Foundation's 2023 Young Investigators Research ForumGlobeNewsWire • 06/14/23